Combination therapy with BRAF and MEK inhibitors for melanoma: latest evidence and place in therapy

Por Eroglu, Zeynep, Ribas, Antoni
Publicado no Ther Adv Med Oncol (2016)

Human Epidermal Growth Factor Receptor Family-Targeted Therapies in the Treatment of HER2-Overexpressing Breast Cancer

Por Eroglu, Zeynep, Tagawa, Tomoko, Somlo, George
Publicado em 2014

Analysis of Circulating Tumor Cells in Breast Cancer

Por Eroglu, Zeynep, Fielder, Odicie, Somlo, George
Publicado em 2013

Combination Therapies for Melanoma: A New Standard of Care?

Por Smalley, Keiran S.M., Eroglu, Zeynep, Sondak, Vernon K.
Publicado no Am J Clin Dermatol (2016)

Phase II clinical trial evaluating docetaxel, vinorelbine and GM-CSF in stage IV melanoma

Por Eroglu, Zeynep, Kong, Kevin M., Jakowatz, James G., Samlowski, Wolfram, Fruehauf, John P.
Publicado em 2011

A phase IB study of ipilimumab with peginterferon alfa-2b in patients with unresectable melanoma

Por Brohl, Andrew S., Khushalani, Nikhil I., Eroglu, Zeynep, Markowitz, Joseph, Thapa, Ram, Chen, Y. Ann, Kudchadkar, Ragini, Weber, Jeffrey S.
Publicado no J Immunother Cancer (2016)

Role of SMC1 in Overcoming Drug Resistance in Triple Negative Breast Cancer

Por Yadav, Sushma, Sehrawat, Archana, Eroglu, Zeynep, Somlo, George, Hickey, Robert, Yadav, Sailee, Liu, Xueli, Awasthi, Yogesh C., Awasthi, Sanjay
Publicado em 2013

Mycophenolate Mofetil-Based Salvage as Acute GVHD Prophylaxis after Early Discontinuation of Tacrolimus and/or Sirolimus

Por Ali, Haris, Palmer, Joycelynne, Eroglu, Zeynep, Stiller, Tracey, Thomas, Sandra H., Khaled, Samer, Shayani, Sepideh, Parker, Pablo, Forman, Stephen J., Nakamura, Ryotaro
Publicado no Bone Marrow Transplant (2014)

Safety and efficacy of anti-PD-1 in patients with baseline cardiac, renal, or hepatic dysfunction

Por Kanz, Bridgette A., Pollack, Megan H., Johnpulle, Romany, Puzanov, Igor, Horn, Leora, Morgans, Alicia, Sosman, Jeffrey A., Rapisuwon, Suthee, Conry, R. Martin, Eroglu, Zeynep, Johnson, Douglas B.
Publicado no J Immunother Cancer (2016)

Long term Survival with CTLA-4 blockade Using Tremelimumab

Por Eroglu, Zeynep, Kim, Dae Won, Wang, Xiaoyan, Camacho, Luis H., Chmielowski, Bartosz, Seja, Elizabeth, Villanueva, Arturo, Ruchalski, Kathleen, Glaspy, John A., Kim, Kevin B., Hwu, Wen-Jen, Ribas, Antoni
Publicado no Eur J Cancer (2015)

Thrombocytopenia in patients with melanoma receiving immune checkpoint inhibitor therapy

Por Shiuan, Eileen, Beckermann, Kathryn E., Ozgun, Alpaslan, Kelly, Ciara, McKean, Meredith, McQuade, Jennifer, Thompson, Mary Ann, Puzanov, Igor, Greer, John P., Rapisuwon, Suthee, Postow, Michael, Davies, Michael A., Eroglu, Zeynep, Johnson, Douglas
Publicado no J Immunother Cancer (2017)

Clinical features of acquired resistance to anti–PD-1 therapy in advanced melanoma

Por Wang, Daniel Y., Eroglu, Zeynep, Ozgun, Alpaslan, Leger, Paul D., Zhao, Shilin, Ye, Fei, Luke, Jason J., Joseph, Richard W., Haq, Rizwan, Ott, Patrick A., Hodi, F. Stephen, Sosman, Jeffrey A., Johnson, Douglas B., Buchbinder, Elizabeth I.
Publicado no Cancer Immunol Res (2017)

Efficacy of Anti-PD-1 Agents in Acral and Mucosal Melanoma

Por Shoushtari, Alexander N., Munhoz, Rodrigo R., Kuk, Deborah, Ott, Patrick A., Johnson, Douglas B., Tsai, Katy K., Rapisuwon, Suthee, Eroglu, Zeynep, Sullivan, Ryan J., Luke, Jason J., Gangadhar, Tara C., Salama, April K. S., Clark, Varina, Burias, Clare, Puzanov, Igor, Atkins, Michael B., Algazi, Alain, Ribas, Antoni, Wolchok, Jedd D., Postow, Michael A.
Publicado no Cancer (2016)

Acquired BRAF inhibitor resistance: a multicenter meta-analysis of the spectrum and frequencies, clinical behavior, and phenotypic associations of resistance mechanisms

Por Johnson, Douglas B., Menzies, Alexander M., Zimmer, Lisa, Eroglu, Zeynep, Ye, Fei, Zhao, Shilin, Rizos, Helen, Sucker, Antje, Scolyer, Richard A., Gutzmer, Ralf, Gogas, Helen, Kefford, Richard F., Thompson, John F., Becker, Jürgen C., Berking, Carola, Egberts, Friederike, Loquai, Carmen, Goldinger, Simone M., Pupo, Gulietta M., Hugo, Willy, Kong, Xiangju, Garraway, Levi A., Sosman, Jeffrey A., Ribas, Antoni, Lo, Roger S., Long, Georgina V., Schadendorf, Dirk
Publicado no Eur J Cancer (2015)

Yabancı Dil Olarak Dijital Türkçe Öğretimi

Por NACAKÇIOĞLU, Ali, ERCAN GÜVEN, Aliye Nur, OKUR, Alparslan, ATAK, Ata, EROĞLU, Aysun, KOÇ, Burcu, DEMİRCİOĞLU DİREN, Deniz, BOZYİĞİT, Elif, ALPER, Eliz, ÖZCAN, Erdal, İNAL, Ezgi, GÖÇEN, Gökçen, ARI, Gökhan, DEMİRDÖVEN, Gökhan Haldun, GÜNGÖR, Haluk, YURTSEVEN YILMAZ, Hatice, DUMAN, İbrahim, YEŞİL, Lamia Büşra, HORZUM, Mehmet Barış, ERDİL, Melike, TOPAL, Murat, YAŞAR, Mustafa Serdar, AZİZOĞLU, Nahide İrem, İPEK, Ozan, ÇANGIR, Ömer Faruk, EROĞLU, Safa, DEMİR, Seda, ÜNGÖREN, Yasin, ŞENYİĞİT, Yunus, EROĞLU, Zeynep, DEMİR, Süleyman, GÜRBÜZ US, Rabia
Publicado em 2023-12

sFRP2 in the aged microenvironment drives melanoma metastasis and therapy resistance

Por Kaur, Amanpreet, Webster, Marie R., Marchbank, Katie, Behera, Reeti, Ndoye, Abibatou, Kugel, Curtis H., Dang, Vanessa M., Appleton, Jessica, O’Connell, Michael P., Cheng, Phil, Valiga, Alexander A., Morissette, Rachel, McDonnell, Nazli B., Ferrucci, Luigi, Kossenkov, Andrew V., Meeth, Katrina, Tang, Hsin-Yao, Yin, Xiangfan, Wood, William H., Lehrmann, Elin, Becker, Kevin G., Flaherty, Keith T., Frederick, Dennie T., Wargo, Jennifer A., Cooper, Zachary A., Tetzlaff, Michael T., Hudgens, Courtney, Aird, Katherine M., Zhang, Rugang, Xu, Xiaowei, Liu, Qin, Bartlett, Edmund, Karakousis, Giorgos, Eroglu, Zeynep, Lo, Roger S., Chan, Matthew, Menzies, Alexander M., Long, Georgina V., Johnson, Douglas B., Sosman, Jeffrey, Schilling, Bastian, Schadendorf, Dirk, Speicher, David W., Bosenberg, Marcus, Ribas, Antoni, Weeraratna, Ashani T.
Publicado no Nature (2016)